Published • loading... • Updated
Angelini Pharma Acquires Catalyst Pharmaceuticals for 4.1 Billion to Enter the United States.
Summary by Actualidad.es
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Angelini Pharma agrees to acquire Catalyst Pharmaceuticals for $4.1 billion to create a platform focused on brain health and rare diseases Read more Angelini Pharma acquires Catalyst Pharmaceuticals for $4.1 billion to enter the U.S. in News.es.
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
